Carboplatin-paclitaxel bevacizumab followed by the addition of erlotinib to bevacizumab beyond progression in patients with advanced NSCLC
Fulltext:
167850.pdf
Embargo:
until further notice
Size:
60.16Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2016Author(s)
Number of pages
1 p.
Source
Journal of Thoracic Oncology, 11, 4 Suppl, (2016), pp. S132ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Medical Oncology
Geriatrics
Pulmonary Diseases
Journal title
Journal of Thoracic Oncology
Volume
vol. 11
Issue
iss. 4 Suppl
Languages used
English (eng)
Page start
p. S132
Page end
p. S132
Subject
Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences; Radboudumc 13: Stress-related disorders DCMN: Donders Center for Medical Neuroscience; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 1: Alzheimer`s disease DCMN: Donders Center for Medical NeuroscienceThis item appears in the following Collection(s)
- Academic publications [245262]
- Electronic publications [132599]
- Faculty of Medical Sciences [93207]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.